| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.098 | 0.09 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.084 | 0.09 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.09 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.096 | 0.09 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.09 |